Cite

    Lin, F., Guo, C., Yang, Q., Chen, Y., Ke, C., Sai, K., Zhang, J., Jiang, X., Hu, W., Xi, S., Zhou, J., Li, D., Zhou, Z., Zhao, Q., Cao, X., & Chen, Z. (n.d.). sYST-04 PRELIMINARY REPORT OF A CLINICAL TRIAL EVALUATING THE SAFETY AND EFFICIENCY OF NEOADJUVANT CAMRELIZUMAB AND APATINIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS: A PROSPECTIVE, PHASE II, SINGLE-ARM STUDY. Neuro-oncology advances, 4, i21. http://access.bl.uk/ark:/81055/vdc_100161164502.0x000006